Abstract CT056: Durable complete responses to adoptive cell transfer using tumor infiltrating lymphocytes (TIL) in non-small cell lung cancer (NSCLC): A phase I trial

Small Cell ◽

Adoptive Cell Transfer ◽

Cell Transfer ◽

Small Cell Lung ◽

Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy (CRT) for Patients with Locally Advanced Non–small-cell Lung Cancer (LANSCLC): A Phase I Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.266 ◽

2009 ◽

Vol 75 (3) ◽

pp. S110 ◽

Cited By ~ 1

Author(s):

J.H. Heinzerling ◽

R.S. Hughes ◽

R. Govindan ◽

J.D. Bradley ◽

J.D. Schiller ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Locally Advanced ◽

Small Cell ◽

IL-9 Producing Tumor-Infiltrating Lymphocytes (Til) and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3944543 ◽

2021 ◽

Author(s):

Lisanne Heim ◽

Mircea T. Chiriac ◽

Katerina Kachler ◽

Sarah Mitsch ◽

Zuqin Yang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tumor Cells ◽

Cell Lung Cancer ◽

Immune Escape ◽

Small Cell ◽

Small Cell Lung ◽

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1772-z ◽

2011 ◽

Vol 69 (2) ◽

pp. 563-571 ◽

Cited By ~ 10

Author(s):

Heather A. Wakelee ◽

Chris H. Takimoto ◽

Arturo Lopez-Anaya ◽

Quincy Chu ◽

Gary Middleton ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

p53 gene therapy for non-small cell lung cancer: a preliminary report of phase I trial

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)47621-x ◽

2000 ◽

Vol 82 ◽

pp. 36

Author(s):

Toshivoshi Fujiwara ◽

Masafumi Kataoka ◽

Atsushi Nakamura ◽

Noriaki Tanaka

Keyword(s):

Lung Cancer ◽

Gene Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Preliminary Report ◽

Phase I Trial ◽

P53 Gene ◽

Small Cell ◽

HLA-A Locus-Restricted and Tumor-Specific CTLs in Tumor-Infiltrating Lymphocytes of Patients with Non-Small Cell Lung Cancer

Cellular Immunology ◽

10.1006/cimm.1996.1062 ◽

1997 ◽

Vol 175 (2) ◽

pp. 101-110 ◽

Cited By ~ 8

Author(s):

Naoko Seki ◽

Tomoaki Hoshino ◽

Megumi Kikuchi ◽

Akihiro Hayashi ◽

Kyogo Itoh

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Specific Ctls ◽

P-575 Preclinical and preliminary phase I trial results of motexafin gadolinium (MGd) with docetaxel & cisplatin in non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)81068-2 ◽

2005 ◽

Vol 49 ◽

pp. S269-S270

Author(s):

D. Stewart ◽

Y. Oh ◽

R. Schaerer ◽

L. Naumobski ◽

S. Phan

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Small Cell Lung ◽

Motexafin Gadolinium ◽

Preliminary Phase

High-dose tamoxifen in combination with cisplatin in non-small cell lung cancer (NSCLC): Phase I trial and pharmacokinetic analysis

Lung Cancer ◽

10.1016/0169-5002(94)94216-1 ◽

1994 ◽

Vol 11 ◽

pp. 116

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Pharmacokinetic Analysis ◽

High Dose ◽

P-578 A phase I trial of gemcitabine, carboplatin or gemcitabine paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

Lung Cancer ◽

10.1016/s0169-5002(05)81071-2 ◽

2005 ◽

Vol 49 ◽

pp. S270

Author(s):

S. Swann ◽

H. Choy ◽

C. Walter ◽

G. Whipple ◽

W. Demas ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/j.lungcan.2012.11.017 ◽

2013 ◽

Vol 79 (3) ◽

pp. 270-275 ◽

Cited By ~ 11

Author(s):

Se Hyun Kim ◽

Hyo Sup Shim ◽

Jaeho Cho ◽

Jae Heon Jeong ◽

Sun Mi Kim ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Abstract CT173: A phase II study to assess the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-145) alone and in combination with anti-PD-L1 inhibitor durvalumab (MEDI4736) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

10.1158/1538-7445.am2018-ct173 ◽

2018 ◽

Author(s):

Sylvia Lee ◽

Viktoriya Villaflor ◽

Missack Haigentz ◽

Kumar Karyampudi ◽

Susie Tanamly ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Autologous Tumor ◽

Efficacy And Safety ◽

Small Cell Lung ◽